PL2268308T3 - Szczepionka ochronna przeciwko lawsonia intracellularis - Google Patents

Szczepionka ochronna przeciwko lawsonia intracellularis

Info

Publication number
PL2268308T3
PL2268308T3 PL09753743T PL09753743T PL2268308T3 PL 2268308 T3 PL2268308 T3 PL 2268308T3 PL 09753743 T PL09753743 T PL 09753743T PL 09753743 T PL09753743 T PL 09753743T PL 2268308 T3 PL2268308 T3 PL 2268308T3
Authority
PL
Poland
Prior art keywords
vaccine against
lawsonia intracellularis
protective vaccine
against lawsonia
protective
Prior art date
Application number
PL09753743T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2268308(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2268308T3 publication Critical patent/PL2268308T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL09753743T 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis PL2268308T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738 2008-11-06
EP09753743.5A EP2268308B2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars
PCT/EP2009/054516 WO2009144088A2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars

Publications (1)

Publication Number Publication Date
PL2268308T3 true PL2268308T3 (pl) 2018-07-31

Family

ID=41212183

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09753743T PL2268308T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Country Status (13)

Country Link
US (3) US20110033496A1 (pl)
EP (3) EP3708186A1 (pl)
JP (2) JP6026106B2 (pl)
CN (1) CN102006883A (pl)
BR (1) BR122019000869B1 (pl)
CA (1) CA2717969C (pl)
DK (2) DK2268308T3 (pl)
ES (1) ES2666671T3 (pl)
FR (1) FR21C1002I1 (pl)
HU (2) HUE038294T2 (pl)
PL (2) PL2268308T3 (pl)
TW (1) TWI551295B (pl)
WO (1) WO2009144088A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
EP2499233B1 (en) 2009-11-09 2016-11-02 Intervet International B.V. Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
EP3076995B1 (en) 2013-12-03 2020-03-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
CA2931137C (en) 2013-12-03 2023-03-14 Intervet International B.V. Vaccine against porcine circo virus type 2
JP6484241B2 (ja) * 2013-12-03 2019-03-13 インターベット インターナショナル ベー． フェー． ＰＲＲＳおよびローソニア・イントラセルラリス（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）に対するブタワクチン
EP3253409B1 (en) 2015-02-04 2020-05-06 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
EP3253410B1 (en) 2015-02-04 2020-05-06 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig
KR102748051B1 (ko) * 2015-10-22 2024-12-27 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스에 의한 감염으로 발생하는 장애로부터 mda 양성 동물을 보호하기 위한 백신
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
MX2020005584A (es) 2017-12-04 2020-09-14 Intervet Int Bv Vacunacion con particulas de replicon y adyuvante oleoso.
US12290556B2 (en) 2017-12-18 2025-05-06 Intervet Inc. Swine influenza a virus vaccine
JP7139437B2 (ja) * 2018-02-28 2022-09-20 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー 動物内のスカトール及び／又はインドールの低減方法
EP4168041A1 (en) 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes
US20230277649A1 (en) 2020-06-19 2023-09-07 Intervet Inc. Swine influenza a virus vaccine comprising two distinct rna replicon particles
CN115836082A (zh) 2020-06-19 2023-03-21 英特维特国际股份有限公司 包含编码特定病毒谱系抗原的核酸构建体的甲型猪流感病毒疫苗
WO2021255225A1 (en) 2020-06-19 2021-12-23 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
CN118139640A (zh) 2021-10-25 2024-06-04 英特维特国际股份有限公司 保护仔猪抵抗甲型猪流感病毒感染的疫苗
WO2023073640A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Immunogenic gel compositions
US20260103674A1 (en) 2022-09-27 2026-04-16 Intervet Inc. A method of culturing lawsonia intracellularis bacteria
EP4731748A1 (en) 2023-06-23 2026-04-29 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2025262123A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Veterinary vaccines against enteric diseases
WO2025262124A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Adjuvanted veterinary vaccines against enteric diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69015222T2 (de) 1989-02-04 1995-05-04 Akzo Nv Tocole als Impfstoffadjuvans.
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
JP2000502054A (ja) * 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． 治療用および診断用の組成物
EP1177213A4 (en) * 1999-05-13 2002-08-28 Pfizer Prod Inc LAWSONIA DERIVATIVE GENE, POLYPEPTIDES, PEPTIDES AND HEMOLYSIN PROTEINS AND USES THEREOF
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
EP1324768A2 (en) 2000-09-29 2003-07-09 The Arizona Board of Regents on Behalf of the University of Arizona Vaccines for proliferative ileitis
DE60120621T2 (de) 2000-12-20 2006-12-14 Intervet International B. V. Lawsonia intracellularis Impfstoff
UA87665C2 (ru) 2003-07-25 2009-08-10 Берингер Ингельхайм Ветмедика, Инк. Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
BRPI0507017A (pt) 2004-01-22 2007-06-05 Intervet Int Bv ácido nucleico que codifica uma proteìna de lawsonia intracellularis, fragmento de dna, molécula de dna recombinante, carreador recombinante vivo, célula hospedeira, proteìna de lawsonia intracellularis, uso da mesma, vacina para combater as infecções por lawsonia intracellularis, método para preparação da mesma, e, teste de diagnóstico
JP5393978B2 (ja) * 2004-04-05 2014-01-22 ゾエティス・ピー・エルエルシー マイクロ流動化された水中油型乳剤及びワクチン組成物
EP2298340B1 (en) * 2004-09-22 2014-04-16 GlaxoSmithKline Biologicals S.A. Immunogenic composition for use in vaccination against staphylococcei
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
DK1926496T3 (da) 2005-09-09 2013-09-30 Intervet Int Bv PCV-2-vaccine
EP1991262A4 (en) 2006-03-03 2009-11-04 Merial Ltd MYCOPLASMA HYOPNEUMONIAE VACCINE
MY148405A (en) * 2006-03-30 2013-04-30 Glaxosmithkline Biolog Sa Immunogenic composition
WO2007116032A1 (en) 2006-04-10 2007-10-18 Intervet International B.V. Vaccine against mycoplasma prrsv
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
WO2007138036A1 (en) 2006-05-30 2007-12-06 Intervet International B.V. Vaccine against rickettsia-like organisms
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
EP3253409B1 (en) 2015-02-04 2020-05-06 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig

Also Published As

Publication number Publication date
BRPI0909769A2 (pt) 2015-08-11
EP3351267B1 (en) 2020-08-05
EP3351267A1 (en) 2018-07-25
JP2016026154A (ja) 2016-02-12
HUE038294T2 (hu) 2018-10-29
JP2011516600A (ja) 2011-05-26
JP6138875B2 (ja) 2017-05-31
WO2009144088A2 (en) 2009-12-03
US20130302372A1 (en) 2013-11-14
TW201002342A (en) 2010-01-16
JP6026106B2 (ja) 2016-11-16
DK2268308T3 (en) 2018-05-22
EP2268308B1 (en) 2018-03-14
WO2009144088A3 (en) 2010-05-06
EP3708186A1 (en) 2020-09-16
US20110033496A1 (en) 2011-02-10
PL3351267T3 (pl) 2020-11-30
CA2717969A1 (en) 2009-12-03
EP2268308B2 (en) 2026-05-06
DK3351267T3 (da) 2020-09-21
US8597662B2 (en) 2013-12-03
FR21C1002I1 (fr) 2021-03-05
CN102006883A (zh) 2011-04-06
HUS2000047I1 (hu) 2020-12-28
CA2717969C (en) 2016-06-07
ES2666671T3 (es) 2018-05-07
TWI551295B (zh) 2016-10-01
BR122019000869B1 (pt) 2023-11-07
EP2268308A2 (en) 2011-01-05
US9198963B2 (en) 2015-12-01
US20130045228A1 (en) 2013-02-21

Similar Documents

Publication Publication Date Title
PL3351267T3 (pl) Szczepionka ochronna przeciwko lawsonia intracellularis
BRPI1006851A2 (pt) luva protetora
DK2229572T3 (da) Rekuperator
BRPI0920721A2 (pt) luva corrediça
BRPI1014920A2 (pt) luva
DK2114993T3 (da) Vaccine
BR112012006964A2 (pt) ventilador
BRPI0922878A2 (pt) ventilador
EP2180160A4 (en) TURBOCHARGER
EP2226484A4 (en) TURBOCHARGER
ATE450271T1 (de) Impfstoff
EP2351920A4 (en) TURBOCHARGER
EP2261482A4 (en) TURBOCHARGER
BRPI0820754A2 (pt) Impulsador em dispositivo de embalagem
BRPI0917205A2 (pt) vacina polivalente
BRPI0920240A2 (pt) formulação de adjuvante de combinação
AT507924A3 (de) Gleitelement
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
DE212009000048U8 (de) Schutzhülse
BRPI0921578A2 (pt) vacinas unitemporais
IT1393474B1 (it) Dispositivo indossabile di protezione.
DK2338679T3 (da) Beskyttelsesafdækning
BRPI0919102A2 (pt) vacinas de salmonella não-tifóide
DK2175881T3 (da) Intradermal influenzavaccine
ATE521389T1 (de) Schutzbekleidung